Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 71, Issue 6, 1990, Pages 1508-1518

  Welch, S ^a,b   Gebhart, S S P ^a,b   Bergman, R N ^a,b   Phillips, L S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; TOLBUTAMIDE;

ADULT; ARTICLE; CALORIC RESTRICTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; COMPARATIVE STUDY; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN; MALE; MIDDLE AGE; MODELS, BIOLOGICAL; SUPPORT, U.S. GOV'T, P.H.S.; TOLBUTAMIDE;

EID: 0025605915     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-71-6-1508     Document Type: Article

References (42)

1. Pfeifer MS, Holter JB, Porte D. Insulin secretion in diabetes mellitus. Am J Med. 1981;70:579-88.
2. Pacini G, Finegood DT, Bergman RN. A minimal model based glucose clamp yielding insulin sensitivity independent of glycemia. Diabetes. 1982;31:432-41.
3. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev. 1985;6:45-86.
4. Bergman RN, Beard JC, Chen M. The minimal modelling method: assessment of insulin sensitivity and B-cell function in vivo. In: Clarke WL, Larner J, Pohl SL, eds. Methods in diabetes research. New York: Wiley and Sons; 1986;15-34.
5. Andres R, Swerloff R, Pozefsky T, Coleman D. Manual feedback technique for the control of blood glucose concentration. In: Skeggs JR, ed. Automation in analytical chemistry. New York: Mediad; 1966;486.
6. Insel PA, Liljenquest JE, Tobin JD, et al. Insulin control of glucose metabolism in man: a new kinetic approach. J Clin Invest. 1975;55:1057-66.
7. Hamwi GJ. Therapy: changing dietary concepts. In: Danowski TS, ed. Diabetes mellitus: diagnosis and treatment. New York: American Diabetes Association; 1964;73-8.
8. Lee J, Kolonel LN. Body mass indices: a further commentary. Am J Clin Nutr. 1983;38:660-1.
9. Ashwell M, Chen S, Stalley S, Garrow SJ. Female fat distribution: a simple classification based on two circumference measurements. Int J Obesity. 1982;6:143-52.
10. McGuire EAH, Helderman JH, Tobin JD, Andres R, Berman M. Effect of arterial versus venous sampling on analysis of glucose kinetics in man. Appl Physiol. 1976;41:565-72.
11. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and B-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 1981;68:1456-67.
12. Beard JC, Bergman RN, Ward WK, Porte Jr D. The insulin sensitivity index in man: correlation between clamp-derived and IVGTT-derived values. Diabetes. 1986;35:362-9.
13. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic clamp. J Clin Invest. 1987;79:790-900.
14. Herbert V, Lau K-S, Gottlieb CW, Bleicher JS. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965;25:1375-84.
15. Baron AD, Wallace P, Brechtel G. In vivo regulation of noninsulin-mediated and insulin-mediated glucose uptake by cortisol. Diabetes. 1987;36:1230-7.
16. Baron AD, Wallace P, Olefsky JM. In vivo regulation of noninsulin-mediated and insulin-mediated glucose uptake by epinephrine. J Clin Endocrinol Metab. 1987;64:889-95.
17. Baron AD, Brechtel G, Wallace P, Edelman SV. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol. 1988;255:E769-74.
18. Tilliop S, Bogardus C. Obesity and insulin resistance: lessons learned from the Pima Indians. Diabet/Metab Rev. 1988;4:517-40.
19. Finegood DT, Pacini G, Bergman RN. The insulin sensitivity index: correlation in dogs between values determined from the intravenous glucose tolerance test and the euglycemic glucose clamp. Diabetes. 1984;33:362.
20. Donner CC, Fraze E, Chen L-DI, Hollenbeck CB, Foley JE, Reaven GM. Presentation of a new method for specific measurement of in vivo insulin stimulated glucose disposal in humans: comparison of this approach with the insulin clamp and minimal model techniques. J Clin Endocrinol Metab. 1985;60:723-6.
21. Tranberg K, Thorell J. Variation in the disappearance of unlabeled insulin from plasma: studies with portal and peripheral infusions. Diabetes. 1979;28:846-51.
22. Gavin JR. Dual actions of sulfonylurea and glyburide. Receptor and post-receptor effects. Am J Med. 1985;79:34-42.
23. Amatruda JM, Salhanick AI, Chang CL. Hepatic insulin resistance in noninsulin-dependent diabetes mellitus and the effects of a sulfonylurea in potentiating insulin action. Diabetes Care. 1984;7(Suppl 1):47-53.
24. Kolterman OG, Olefsky JM. The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes. Diabetes Care. 1984;7(Suppl 1):81-8.
25. Defronzo RA, Simonson DC. Oral sulfonylurea agents suppress hepatic glucose production in noninsulin-dependent diabetic individuals. Diabetes Care. 1984;7(Suppl 1):72-80.
26. Defronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes. 1983;32:35-45.
27. Bergman RN. Integrated control of hepatic glucose metabolism. Fed Proc. 1977;36:265-70.
28. Prager R, Wallace P, Olefsky JM. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes. 1987;36:607-11.
29. Ader M, Bergman RN. Peripheral effects of insulin dominate suppression of hepatic glucose production. Am J Physiol. 1990;258:E1020-32.
30. Kolterman OG, Gray RS, Griffin GJ, et al. Receptor and postreceptor effects contribute to the insulin resistance in noninsulindependent diabetes mellitus. J Clin Invest. 1981;68:957-69.
31. Bergman RN, Ader YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979;236:667.
32. Raghu P, Johnston C, Beard JC, Bergman RN, McCulloch DK, Palmer JP. Reduced insulin sensitivity in non-diabetic HLA-iden-tical siblings of insulin dependent diabetic subjects. Diabetes. 1985;34:991-4.
33. Ward WK, Johnston CLW, Beard JC, Benedetti TJ, Halter JB, Porte Jr D. Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes. 1985;34:861-9.
34. Donner CC, Fraze E, Chen Y-DI, Reaven GM. Quantitation of insulin-stimulated glucose disposal in patients with non-insulindependent diabetes mellitus. Diabetes. 1985;34:831-5.
35. Baron AD, Kolterman OG, Bell J, Mandarino LJ, Olefsky JM. Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest. 1985;76:1782-8.
36. Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah AH. Relationship of body fat to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism. 1984;33:68-75.
37. Defronzo RA. The triumvirate; B-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes. 1988;37:667-87.
38. Bergman RN, Ader M, Finegood DT, Pacini G. Extrapancreatic effect of somatostatin infusion to increase glucose clearance. Am J Physiol. 1984;247:E370-9.
39. Capaldo B, Santoro D, Riccardi G, Perrotti N, Sacco L. Direct evidence for a stimulatory effect of hyperglycemia per se on peripheral glucose disposal in type II diabetes. J Clin Invest. 1986;77:12885-90.
40. Baron AD, Wallace P, Brechtel G, Prager R. Somatostatin does not increase insulin-stimulation glucose uptake in humans. Diabetes. 1987;36:33-6.
41. Baron AD, Brechtel G, Wallace P, Edelman SV. Fasting decreases rates of noninsulin-mediated glucose uptake in man. J Clin Endocrinol Metab. 1988;67:532-40.
42. Bergman RN, Volund A, Yang Y, Youn J, Ader M. Simplified intravenous injection protocol in man yields insulin sensitivity index equal to that from euglycemic clamps. Diabetes. 1986;35:14A.